Bleeding, Cerebral Hypoxia During and/or Resulting From A Procedure, Thrombosis
Conditions
Keywords
Vascular surgery, Antiplatelet, Anticoagulants, complication, trombosis, bleeding
Brief summary
The goal of this retrospective clinical trial is to find out association antiplatelet and anticoagulant therapy with perioperative complications in non-cardiac vascular surgery in patients . The main questions it aims to answer are: Does the use of antiplatelet agents and anticoagulants affect the development of complications in the perioperative period during operations on the main arteries? Does discontinuing antiplatelet and anticoagulant medications affect the development of perioperative complications in major artery surgeries?? Researchers will compare with patients who didn't use antiplatelets and anticoagulant drugs to see ift he incidence of complications comparable? This is a retrospective study based on the analysis of medical records (case histories).
Interventions
DRUGAspirin
Patients who take aspirin until the operation day
DRUGClopidogrel
Patients who take clopidogrel until the operation day
DRUGTicagrelor
Patients who take ticagrelor until the operation day
DRUGDabigatran
Patients who take dabigatran until the operation day
DRUGRivaroxaban
Patients who take rivaroxaban until the operation day
DRUGApixaban
Patients who take apixaban until the operation day
DRUGWarfarin
Patients who take warfarin until the operation day
Patients who take aspirin and clopidogrel until the operation day
Patients who take aspirin and ticagrelor until the operation day
DRUGAspirin + Apixaban
Patients who take aspirin and apixaban until the operation day
DRUGAspirin + rivaroxaban
Patients who take aspirin and rivaroxaban until the operation day
DRUGClopidogrel + Apixaban
Patients who take clopidogrel and apixaban until the operation day
DRUGClopidogrel + Rivaroxaban
Patients who take clopidogrel and rivaroxaban until the operation day
Sponsors
Petrovsky National Research Centre of Surgery
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who received surgical treatment on the main arteries.
Exclusion criteria
* Patients who received surgical treatment on the main veins.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Bleeding | First 24 hours after operation | Case of bleeding or haematoma development |
Secondary
| Measure | Time frame |
|---|---|
| Trombosis | First 24 hours after operation |
Countries
Russia
Outcome results
None listed